[{"id":"4af37b5e-53c0-463d-aa29-d4176aa0cac9","acronym":"","url":"https://clinicaltrials.gov/study/NCT04637503","created_at":"2021-01-19T20:37:37.669Z","updated_at":"2024-07-02T16:36:38.465Z","phase":"Phase 1/2","brief_title":"4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma","source_id_and_acronym":"NCT04637503","lead_sponsor":"Shenzhen Geno-Immune Medical Institute","biomarkers":" CD276","pipe":"","alterations":" ","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 4SCAR-T • GD2, PSMA and CD276 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 11/18/2020","start_date":" 11/18/2020","primary_txt":" Primary completion: 11/19/2020","primary_completion_date":" 11/19/2020","study_txt":" Completion: 12/31/2023","study_completion_date":" 12/31/2023","last_update_posted":"2020-11-19"}]